Please log in to view this page
Username
Password
A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
